Literature DB >> 3219797

Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy.

A W van den Wall Bake1, M R Daha, A van der Ark, P S Hiemstra, J Radl, L A van Es.   

Abstract

Patients with primary IgA nephropathy have deposits of IgA1 in their kidneys, and increased plasma levels of macromolecular IgA1. Total serum IgA concentrations are frequently elevated, but studies on the subclass distribution have been few and conflicting. Several investigators found that production of IgA by peripheral blood lymphocytes in culture is increased. However, the distribution of the IgA subclasses produced has not been studied previously. We studied the serum IgA subclasses in 14 patients with IgA nephropathy, and found a significant (P less than 0.001) increase in IgA1 (3.71 +/- 1.34 mg/ml, mean +/- s.d.) compared with controls (1.77 +/- 1.10 mg/ml). Serum IgA2 was not different in patients and controls. The ratio of serum IgA1 to total IgA was also significantly (P less than 0.001) higher in patients (92.2 +/- 4.9%) than in controls (80.2 +/- 6.6%). Studies of immunoglobulin production by peripheral blood mononuclear cells showed a significant increase in IgA1 synthesis, expressed as a fraction of total IgA synthesis in unstimulated cultures (P less than 0.05) and in PWM stimulated cultures (P less than 0.01). Polymeric IgA and polymeric IgA1 production were not higher in patients than in controls. IgM production in unstimulated cultures was significantly (P less than 0.05) higher in patients than in controls. Together with the observed deposition of exclusively IgA1 in the mesangium, our results indicate that patients with IgA nephropathy preferentially produce antibodies of the IgA1 subclass.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3219797      PMCID: PMC1541711     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

1.  The clinical course of IgA nephropathy in adults.

Authors:  J van der Peet; L Arisz; J R Brentjens; J Marrink; P J Hoedemaeker
Journal:  Clin Nephrol       Date:  1977-08       Impact factor: 0.975

2.  Decrease of IgA-specific suppressor T cell activity in patients with IgA nephropathy.

Authors:  H Sakai; Y Nomoto; S Arimori
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

3.  Immunologic studies in IgA nephropathy.

Authors:  A J Woodroffe; A A Gormly; P E McKenzie; A M Wootton; A J Thompson; A E Seymour; A R Clarkson
Journal:  Kidney Int       Date:  1980-09       Impact factor: 10.612

4.  Circulating immune complexes, the concentration of serum IgA and the distribution of HLA antigens in IgA nephropathy.

Authors:  J Mustonen; A Pasternack; H Helin; A Rilva; K Penttinen; O Wager; A Harmoinen
Journal:  Nephron       Date:  1981       Impact factor: 2.847

5.  Immunoglobulin A1 and IgA nephropathy.

Authors:  Y Tomino; M Endoh; Y Nomoto; H Sakai
Journal:  N Engl J Med       Date:  1981-11-05       Impact factor: 91.245

6.  Increased rates of polymeric IgA synthesis by circulating lymphoid cells in IgA mesangial glomerulonephritis.

Authors:  J Egido; R Blasco; J Sancho; L Lozano; M Sanchez-Crespo; L Hernando
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

7.  IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA.

Authors:  M L Trascasa; J Egido; J Sancho; L Hernando
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

8.  The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy.

Authors:  A W van den Wall Bake; M R Daha; J Radl; J J Haaijman; A Van der Ark; R M Valentijn; L A Van Es
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

9.  Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus.

Authors:  M E Conley; M D Cooper; A F Michael
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

10.  Production of predominantly polymeric IgA by human peripheral blood lymphocytes stimulated in vitro with mitogens.

Authors:  W H Kutteh; W J Koopman; M E Conley; M L Egan; J Mestecky
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

View more
  11 in total

1.  Increase in tonsillar germinal centre B-1 cell numbers in IgA nephropathy (IgAN) patients and reduced susceptibility to Fas-mediated apoptosis.

Authors:  S Kodama; M Suzuki; M Arita; G Mogi
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

2.  Increased and prolonged production of specific polymeric IgA after systemic immunization with tetanus toxoid in IgA nephropathy.

Authors:  L Layward; A C Allen; S J Harper; J M Hattersley; J Feehally
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

3.  Granulomatosis with polyangiitis associated with IgA nephropathy.

Authors:  Daisuke Fukuhara; Ryota Kurayama; Yugo Ito; Yoshinori Komagata; Yoshihiro Arimura; Kunimasa Yan
Journal:  CEN Case Rep       Date:  2013-02-20

4.  Expression of IgA class switching gene in tonsillar mononuclear cells in patients with IgA nephropathy.

Authors:  Hong Liu; Youming Peng; Fuyou Liu; Weiwei Xiao; Yu Zhang; Weiwei Li
Journal:  Inflamm Res       Date:  2011-05-26       Impact factor: 4.575

5.  Systemic immune response after mucosal immunization in patients with IgA nephropathy.

Authors:  F B Waldo
Journal:  J Clin Immunol       Date:  1992-01       Impact factor: 8.317

6.  Hypercomplementemia in adult patients with IgA nephropathy.

Authors:  Kisara Onda; Hiroyuki Ohi; Mariko Tamano; Isao Ohsawa; Michiro Wakabayashi; Satoshi Horikoshi; Teizo Fujita; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

7.  Immunopathological features of palatine tonsil characteristic of IgA nephropathy: IgA1 localization in follicular dendritic cells.

Authors:  C Kusakari; M Nose; T Takasaka; R Yuasa; M Kato; K Miyazono; T Fujita; M Kyogoku
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

8.  Light-chain ratio of serum IgA1 in IgA nephropathy.

Authors:  S H Chui; C W Lam; W H Lewis; K N Lai
Journal:  J Clin Immunol       Date:  1991-07       Impact factor: 8.317

9.  Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.

Authors:  Y Wang; M-H Zhao; Y-K Zhang; X-M Li; H-Y Wang
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

10.  Humoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. An analysis of isotype distribution and size of the influenza-specific antibodies.

Authors:  A W van den Wall Bake; W E Beyer; J H Evers-Schouten; J Hermans; M R Daha; N Masurel; L A van Es
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.